Larney, Sarah

$249,900.00 CAD

≈ 3 Canadians' average pay for a year
Department
Canadian Institutes of Health Research
Program
Research in Priority Areas
Recipient country
Canada
Fiscal year
2020-2021
Agreement period
January 1, 2021 – December 31, 2021
Reference
cihr-irsc:236-2020-2021-Q4-00181

Published purpose

The specific objectives of this funding opportunity are to: • Inform best practices for the operation of safer supply interventions and supervised consumption sites • Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context • Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions • Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators • Advance evidence-based practices through knowledge dissemination activities • Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions